Delivery Order SPE2DB20D3103-SPE2DB22FL8X4
Award Date
12/7/21
Potential Completion Date
12/8/21
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including Dupixent 300 mg/2 ml pens, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm-fixed price of $4,570.80 and an ultimate completion date of October 17, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,722.12 contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The award has a Firm Fixed Price pricing type and an ultimate completion date of January 9, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, with a ceiling value of $5,005.47, is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,304.72 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has a ceiling value of $3,304.72 and a completion date of November 7, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $22,405.65 for the supply of Dupixent 300 mg/2 ml pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 28, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $11,668.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period through December 5, 2023. The contract is a Firm Fixed Price Delivery Order, and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,307.83 for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. The award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., is a Delivery Order valued at $21,154.15 for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 2, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award, valued at $5,239.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Dupixent 200 mg/1.14 ml pens, a pharmaceutical product, with an ultimate completion date of April 28, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products, including Dupixent 300 mg/2 ml pens. The contract, valued at $16,272.14, has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...